Company: BioNanomatrix
Funding Raised: $5.1 million
Battelle Ventures, Ben Franklin Technology Partners, KT Venture Group, 21Ventures

Innovation: The nanochannel technology it’s developing could be used to sequence single DNA molecules without reassembling many small sequences into a genome.

Company: Complete Genomics
Funding Raised: $91 million 
Enterprise Partners, OVP Venture Partners, Prospect Venture Partners, Highland Capital Management, Genentech

Innovation: Sequencing human genomes to order

Company: Generation Health
Funding Raised: Not disclosed
CVS Caremark, Highland Capital Partners

Innovation: Manages health benefits related to personalized medicine for insurance companies. As DNA testing becomes more common, this type of company will be increasingly important.

Company: Integrated Diagnostics
Funding Raised: $30 million
InterWest Partners, Wellcome Trust, Dievini Hopp BioTech Holding

Innovation: Is developing diagnostic products based on genetic and protein analyses to look at tens to hundreds of disease markers simultaneously.

Company: Knome
Funding Raised: Not disclosed
Privately funded

Innovation: Will sequence and analyze the complete genome of any individual for $68,500.

Company: Metabolon
Funding Raised: $30 million
Syngenta Ventures, Sevin Rosen Funds, Aurora Funds

Innovation: Analyzes an array of metabolic markers to diagnose diseases or reactions to drugs.

Company: Navigenics
Funding Raised: Over $40 million
Procter and Gamble, Kleiner Perkins Caufield and Byers, Mohr Davidow Ventures

Innovation: Offers genetic testing directly to consumers and encourages doctors to incorporate testing into their practice.

Company: Pacific Biosciences
Funding Raised: $266 million
Wellcome Trust, Mohr Davidow Ventures, Kleiner Perkins Caufield and Byers, Alloy Ventures

Innovation: Accurate sequencing in real time

Company: Proventys
Funding Raised: Not disclosed
Burrill and Company

Innovation: Is developing software that will help doctors use genetic testing and clinical data to make prognoses and determine treatments.

Company: 23andMe
Funding Raised: Not disclosed
Google, Genentech, New Enterprise Associates

Innovation: Sells genetic testing directly to consumers; results include information about ancestry and about the subject’s sensitivity to a range of drugs.


Leave a Reply

You must be logged in to post a comment.